Mn Services Vermogensbeheer B.V. Has $5.80 Million Position in Avantor, Inc. (NYSE:AVTR)

Mn Services Vermogensbeheer B.V. lifted its position in Avantor, Inc. (NYSE:AVTR - Free Report) by 5.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 275,300 shares of the company's stock after purchasing an additional 15,000 shares during the quarter. Mn Services Vermogensbeheer B.V.'s holdings in Avantor were worth $5,801,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in AVTR. Robeco Schweiz AG boosted its holdings in shares of Avantor by 12.5% in the 4th quarter. Robeco Schweiz AG now owns 7,612,555 shares of the company's stock valued at $160,397,000 after buying an additional 848,814 shares during the last quarter. Oregon Public Employees Retirement Fund grew its holdings in shares of Avantor by 0.6% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 138,465 shares of the company's stock worth $2,917,000 after purchasing an additional 765 shares during the last quarter. Illinois Municipal Retirement Fund lifted its stake in shares of Avantor by 101.2% in the fourth quarter. Illinois Municipal Retirement Fund now owns 106,232 shares of the company's stock worth $2,238,000 after acquiring an additional 53,429 shares during the period. Amalgamated Bank lifted its stake in Avantor by 0.3% in the fourth quarter. Amalgamated Bank now owns 325,096 shares of the company's stock valued at $6,850,000 after buying an additional 1,126 shares during the period. Finally, Bank of New York Mellon Corp increased its holdings in shares of Avantor by 1.4% during the fourth quarter. Bank of New York Mellon Corp now owns 4,830,719 shares of the company's stock valued at $101,783,000 after acquiring an additional 68,598 shares in the last quarter. Institutional investors and hedge funds own 95.08% of the company's stock.

Remove Ads

Insider Buying and Selling

In other news, CAO Steven W. Eck sold 4,907 shares of the stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total value of $86,019.71. Following the completion of the transaction, the chief accounting officer now directly owns 40,604 shares in the company, valued at $711,788.12. This trade represents a 10.78 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP James Bramwell sold 3,758 shares of the firm's stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $65,877.74. Following the sale, the executive vice president now owns 87,379 shares of the company's stock, valued at $1,531,753.87. The trade was a 4.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.30% of the stock is owned by corporate insiders.

Avantor Stock Performance

NYSE AVTR traded up $0.25 during trading hours on Wednesday, hitting $15.75. The company had a trading volume of 7,605,768 shares, compared to its average volume of 5,941,737. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.70 and a current ratio of 1.07. Avantor, Inc. has a 1-year low of $15.37 and a 1-year high of $28.00. The company has a market cap of $10.73 billion, a PE ratio of 15.15, a price-to-earnings-growth ratio of 1.55 and a beta of 1.30. The business has a 50 day moving average of $20.18 and a 200-day moving average of $22.47.

Avantor (NYSE:AVTR - Get Free Report) last issued its earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same period in the previous year, the firm earned $0.22 earnings per share. As a group, equities research analysts expect that Avantor, Inc. will post 1.06 EPS for the current year.

Wall Street Analysts Forecast Growth

AVTR has been the topic of a number of recent research reports. Barclays dropped their price target on Avantor from $26.00 to $23.00 and set an "overweight" rating on the stock in a research report on Monday, February 10th. Stifel Nicolaus decreased their price target on Avantor from $28.00 to $26.00 and set a "buy" rating on the stock in a research note on Monday, February 10th. Royal Bank of Canada reduced their target price on Avantor from $33.00 to $31.00 and set an "outperform" rating on the stock in a research note on Monday, February 10th. Raymond James restated an "outperform" rating and set a $24.00 price target (down from $26.00) on shares of Avantor in a research report on Monday, February 10th. Finally, Wells Fargo & Company dropped their target price on Avantor from $28.00 to $25.00 and set an "overweight" rating on the stock in a report on Monday, February 10th. Three analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $25.50.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.